The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
NCT00002368 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2000
Last updated 2005-06-24
Summary
To evaluate the tolerance, safety, and effectiveness of Viramune in preventing clinical AIDS progression events or death when used in combination with Lamivudine and background nucleoside therapy.
Conditions
- HIV Infections
Interventions
- DRUG
-
Nevirapine
- DRUG
-
Lamivudine
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease
NCT00002324 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002418 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients
NCT02184299 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine
NCT00002381 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
NCT00002234 ·Status: COMPLETED ·Phase: PHASE2
-
Nevirapine + 3TC Based Maintenance Therapy for HIV Infection
NCT03223402 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients
NCT00000962 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients
NCT02184078 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
NCT00002194 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients
NCT00001085 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients
NCT00876733 ·Status: COMPLETED
-
Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS
NCT02191215 ·Status: COMPLETED
-
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002430 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell
NCT00002323 ·Status: COMPLETED ·Phase: NA
-
Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine
NCT00000838 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
NCT00002195 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
NCT00158821 ·Status: COMPLETED ·Phase: PHASE3
-
Nevirapine / Lamivudine for HIV Maintenance Therapy
NCT07014189 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
NCT00002347 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
NCT00511368 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Viracept in HIV-Positive Women
NCT00002171 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Elvucitabine in HIV-1 Subjects
NCT00405249 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
NCT00002320 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)
NCT02397096 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)
NCT00495326 ·Status: COMPLETED ·Phase: PHASE2/PHASE3